Zeller P, Legendre A, Jacques S, Fleury M J, Gilard F, Tcherkez G, Leclerc E
Biomécanique et Bioingénierie, Centre de recherche Royallieu, Sorbonne universités, Université de Technologie de Compiègne, CNRS, UMR 7338, Compiègne cedex, France.
INSERM U1193, Physiopathogénèse et Traitement des Maladies du Foie, Hôpital Paul Brousse, bâtiment Lavoisier, Villejuif Cedex, France.
J Appl Toxicol. 2017 Mar;37(3):287-295. doi: 10.1002/jat.3360. Epub 2016 Jul 21.
The lack of a reliable in vitro system to assess reprotoxicity is an emerging problem in the context of European law for Registration, Evaluation, Authorization and Restriction of Chemicals (REACH, 2007), as it requires a reduction in animal utilization for testing. Furthermore, in vitro reprotoxicological tests would be more relevant and greatly improved by integrating both hepatic metabolism and the blood-testis barrier. Here, we took advantage of an integrated insert in a dynamic microfluidic platform (IIDMP) to co-cultivate hepatocytes in biochip and Sertoli cells in the bicameral chamber. This microfluidic tool has been previously demonstrated to be helpful in cell function and/or quality improvement. We demonstrate that permeability of the Sertoli barrier is reduced by dynamic coculture in our system. Exometabolomics analysis reveals that interactions between hepatocytes and Sertoli cells may have been mediated by the polyamines increase and/or mid-chain fatty acid decrease in the circulating medium. These metabolic changes may be involved in permeability reduction by contributing to modifying junction protein quantity and localization. The present study gives an example of IIDMP as an in vitro partitioning/transport model for cell culture and toxicological testing. Further, based on both our previous results using an intestinal-hepatic cell coculture and the present study, IIDMP seems to be well-suited for (i) assessing the dose-response effect of chemicals within the rodent or human male reproductive tract, and (ii) improving the quality of reprotoxicological assays by including hepatic metabolism. Copyright © 2016 John Wiley & Sons, Ltd.
在欧洲化学品注册、评估、授权和限制法规(REACH,2007)的背景下,缺乏可靠的体外系统来评估生殖毒性是一个新出现的问题,因为该法规要求减少用于测试的动物数量。此外,通过整合肝脏代谢和血睾屏障,体外生殖毒性测试将更具相关性且能得到极大改善。在此,我们利用动态微流控平台中的集成插入物(IIDMP),在生物芯片中共同培养肝细胞,并在双腔室中培养支持细胞。此前已证明这种微流控工具有助于改善细胞功能和/或提高细胞质量。我们证明,在我们的系统中,动态共培养可降低支持细胞屏障的通透性。外代谢组学分析表明,肝细胞与支持细胞之间的相互作用可能是由循环培养基中多胺增加和/或中链脂肪酸减少介导的。这些代谢变化可能通过改变连接蛋白的数量和定位来参与通透性的降低。本研究给出了一个将IIDMP作为细胞培养和毒理学测试的体外分配/运输模型的例子。此外,基于我们之前使用肠-肝细胞共培养的结果以及本研究,IIDMP似乎非常适合(i)评估化学品在啮齿动物或人类雄性生殖道内的剂量反应效应,以及(ii)通过纳入肝脏代谢来提高生殖毒性试验的质量。版权所有© 2016约翰威立父子有限公司。